Cite
HARVARD Citation
Silberstein, S. et al. (2019). The Effect of Beginning Treatment With Fremanezumab on Headache and Associated Symptoms in the Randomized Phase 2 Study of High Frequency Episodic Migraine: Post‐Hoc Analyses on the First 3 Weeks of Treatment. Headache. 59 (3), pp. 383-393. [Online].